KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Profit After Tax (2018 - 2025)

Historic Profit After Tax for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$33.6 million.

  • BioNTech SE's Profit After Tax fell 11542.21% to -$33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$631.2 million, marking a year-over-year decrease of 2574.71%. This contributed to the annual value of -$710.9 million for FY2024, which is 17102.64% down from last year.
  • BioNTech SE's Profit After Tax amounted to -$33.6 million in Q3 2025, which was down 11542.21% from -$437.6 million recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Profit After Tax peaked at $4.2 billion during Q1 2022, and registered a low of -$869.9 million during Q2 2024.
  • Over the past 5 years, BioNTech SE's median Profit After Tax value was $492.7 million (recorded in 2023), while the average stood at $1.1 billion.
  • Its Profit After Tax has fluctuated over the past 5 years, first soared by 82798755377.65% in 2021, then plummeted by 31957.5% in 2024.
  • BioNTech SE's Profit After Tax (Quarter) stood at $3.6 billion in 2021, then tumbled by 35.81% to $2.3 billion in 2022, then tumbled by 78.81% to $492.7 million in 2023, then tumbled by 43.72% to $277.3 million in 2024, then plummeted by 112.1% to -$33.6 million in 2025.
  • Its Profit After Tax was -$33.6 million in Q3 2025, compared to -$437.6 million in Q2 2025 and -$437.4 million in Q1 2025.